Spontaneous clear or bloody nipple discharge should be reported. Repeated episodes of mastitis in the same area of the breast may be of concern because an underlying problem such as a tumor could be causing it to reoccur. A rare form of breast cancer may appear as a red breast with no fever.
Hormones like estrogen and progesterone are chemicals produced by glands in the body. Normally, these hormones help regulate body cycles, like menstruation. However, sometimes these same hormones can cause cancer to grow.
In some cases, however, it is possible for breast cancer survivors to nurse their babies. And as we all know, nursing has a host of benefits for both baby and mother, not least of which is reduction in breast cancer risk for Mom. Plan ahead.
Curious about breast-feeding beyond infancy? Know the benefits, the role breast milk plays in an older baby's diet and how to handle others' opinions on the topic. If you plan to continue breast-feeding your baby you might have questions about the process. Get the facts about breast-feeding beyond infancy.
The causation of breast cancer in certain strains of mice by a virus that can be transmitted vertically, through the milk produced during lactation, has led to the hypothesis that a similar phenomenon could exist in humans. There have been laboratory-based studies in humans suggesting that a virus may be involved in the etiology of female breast cancer although other investigations did not support this hypothesis. Descriptive data and epidemiologic evidence of ecologic nature do not indicate a role of lactation in the causation of human breast cancer, but the hypothesis has not been adequately assessed in analytic epidemiologic studies.
Breast-feeding can be challenging. Consider breast-feeding tips for new moms, from asking for help right away to letting baby set the pace. You know the benefits of breast-feeding.
DESIGN--Population based case-control study designed primarily to investigate the relation between oral contraceptives and risk of breast cancer; data obtained from questionnaires administered by interviewers, general practitioner notes, and family planning clinic records. One control per case, matched for age, was selected from the list of the case's general practitioner. Breast feeding each baby for longer than three months conferred no additional benefit.
Objective : Breast feeding is associated with reduced estrogen, a profile that should be associated with decreased endometrial cancer incidence. We analyzed data from a population-based case—control study of Wisconsin women to evaluate the relation between lactation and endometrial cancer risk. Breast feeding practices and other factors were ascertained by telephone interview. Results : Compared with parous women who did not breast feed, the multivariate relative risk for women who breast fed for at least 2 weeks was 0.
Differences in the incidence and outcome of breast cancer among Hispanic women compared with white women are well documented and are likely explained by ethnic differences in genetic composition, lifestyle, or environmental exposures. A population-based study was conducted in Galicia, Spain. A total of women diagnosed with operable invasive breast cancer between and participated in the study.
Breast-feeding is not only good for babies but appears to be beneficial to mothers who are diagnosed with breast cancer later in life, a new Kaiser Permanente study of hundreds of Northern California women has found. Looking at the medical histories of more than 1, women diagnosed with breast cancer, researchers discovered that those who had breast-fed had a 30 percent lower risk of recurrence of the disease after effective treatment and tended to have less aggressive tumor types than those who had not breast-fed. The researchers saw improved breast-cancer outcomes among women who had breast-fed, but in addition found that those who breast-fed for a total of six months or longer fared even better throughout the nine-year follow-up period, which ended last year. The study found women who had breast-fed for at least six months had a 37 percent reduced risk of breast-cancer recurrence after treatment.